Drugs / Dispepril®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07655219 | Jun → Nov 2026 expected | voice disorders | Liaquat University of Medical & Health Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dispepril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07655219 ↗ |
| Route | Oral | “One tablet will be taken approximately 15 minutes before lunch and one tablet approximately 15 minutes before dinner.” NCT07655219 ↗ |